CSF acetylcholinesterase in Parkinson disease: decreased enzyme activity and immunoreactivity in demented patients.
Konings
C H
CH
Department of Clinical Chemistry, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands.
Kuiper
M A
MA
Mulder
C
C
Calliauw
J
J
Wolters
E C
EC
D000110:Acetylcholinesterase / Q000134:cerebrospinal fluid* / Q000276:immunology; D000367:Age Factors; D000368:Aged; D015415:Biomarkers / Q000134:cerebrospinal fluid; D003704:Dementia / Q000134:cerebrospinal fluid / Q000150:complications / Q000201:enzymology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000150:complications / Q000201:enzymology*; D012737:Sex Factors
D015415:Biomarkers; D007980:Levodopa; D000110:Acetylcholinesterase